Evidence map›Paper›PMID 32728802›Full record

ArticleMikrochimica acta2020

Self-assembled biotin-phenylalanine nanoparticles for the signal amplification of surface plasmon resonance biosensors.

Ting Sun, Yintang Zhang, Feng Zhao, Ning Xia, Lin Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ting SunSchool of Chemistry and Materials Science, Guizhou Education University, GaoXin Road 115,, Wudang District, 550000, Guizhou, People's Republic of China.
Yintang ZhangCollege of Chemistry and Chemical Engineering, Anyang Normal University, Anyang, 455000, Henan, People's Republic of China.
Feng ZhaoSchool of Chemistry and Materials Science, Guizhou Education University, GaoXin Road 115,, Wudang District, 550000, Guizhou, People's Republic of China. zhaofeng@aynu.edu.cn.
Ning XiaHenan Key Laboratory of Biomolecular Recognition and Sensing, Shangqiu Normal University, Shangqiu, 476000, Henan, People's Republic of China.
Lin LiuHenan Key Laboratory of Biomolecular Recognition and Sensing, Shangqiu Normal University, Shangqiu, 476000, Henan, People's Republic of China. liulin@aynu.edu.cn.ORCID http://orcid.org/0000-0001-7982-6005

Funding

National Natural Science Foundation of China 21804002Program for Science and Technology Innovation Talents at the University of Henan Province 18HASTIT005the Research Funds for the Henan Key Laboratory of Biomolecular Recognition and Sensing HKLBRSK1902
6 · The paper itself

Abstract

A strategy for amplifying the signal of surface plasmon resonance (SPR) biosensors is reported. Biotinylated phenylalanine (Biotin-Phe) monomers were rapidly self-assembled into nanoparticles in a mild environment. The self-assembled nanoparticles were then used as the carriers of streptavidin-antibody complexes by the streptavidin-biotin interaction. The signal was amplified because of the high molecular weight of the nanoparticle-streptavidin-antibody conjugate. With prostate-specific antigen as a model analyte, the target concentration as low as 1 pg mL

Indexed as

Antibodies, ImmobilizedBiotinHumansLimit of DetectionMaleNanoparticlesPhenylalanineProstate-Specific AntigenStreptavidinSurface Plasmon ResonanceAntibodies, ImmobilizedBiotinPhenylalanineProstate-Specific AntigenStreptavidinBiotinPhenylalanineProstate-specific antigenSelf-assemblySignal amplificationSurface plasmon resonance

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.